Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial
Open accessThe DOI matches its Crossref record.
Abstract
Objective: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled trial (RCT) with breast and gynecological cancer survivors evaluated the efficacy of a cognitive-existential fear of recurrence therapy (FORT) compared to an attention placebo control group (living well with cancer [LWWC]) on FCR. Method: One hundred and sixty-four women with clinical levels of FCR and cancer distress were randomly assigned to 6-weekly, 120 min FORT (n= 80) or LWWC (n= 84) group sessions. They completed questionnaires at baseline (T1), posttreatment (T2; primary endpoint), 3 (T3), and 6 months (T4) posttreatment. Generalized linear models were used to compare group differences in the fear of cancer recurrence inventory (FCRI) total score and secondary outcomes. Results: FORT participants experienced greater reductions from T1 to T2 on FCRI total with a between-group difference of−9.48 points ( p=.0393), resulting in a medium effect of−0.530, with a maintained effect at T3 ( p=.0330) but not at T4. For the secondary outcomes, improvements were in favor of FORT, including FCRI triggers ( p=.0208), FCRI coping ( p=.0351), cognitive avoidance ( p=.0155), need for reassurance from physicians ( p=.0117), and quality of life (mental health; p=.0147). Conclusions: This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains © 2023 American Psychological Association
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cancer survivors in the experimental arm experienced FCR reductions five times greater than those in the control group (moderate effect size; d = − 0.53) [44].”
In the citing paper
“The Fear Of Recurrence Therapy (FORT) is a standardized and manualized intervention that consists of six consecutive weekly sessions [43–45].”
In the citing paper
“In addition, compared to the control group, the experimental arm experienced significant decreases in secondary outcomes [triggers, (d = − 0.415), coping (d = − 0.244), cognitive avoidance (d = − 0.424), QoL mental health (d = 0.165)], with sustained improvements at the 3-month follow up.”
In the citing paper
“A large multisite RCT of FORT was subsequently completed with 136 women cancer survivors who were either randomized to FORT or a structurally equivalent support group.”
In the citing paper
“FORT’s pilot [43] and RCT [44, 46] studies demonstrated good questionnaire completion rates.”
Citations
Cited by
Lamarche, J., Cusson, A., Nissim, R., Avery, J., Wong, J., Maheu, C., Lambert, S. D., Laizner, A. M., Jones, J., Esplen, M. J., et al. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1129536 · Cited by 18
“Frontiers in Digital Health 03 (40) with sustained improvements at a 3-month follow up.”
BackgroundSelf-citationSmith, A. B., Girgis, A., Taylor, N. J., Pearce, A. M., Liu, J., Shepherd, H. L., Wu, V. S., Garvey, G., Kirsten, L. T., Zakhary, I., et al. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01685-1 · Cited by 22
Maheu, C., Tock, W. L., Fisher, P., Galica, J., Singh, M. D., Centeno, I., Hébert, M., Moran, C., Pietruczuk, P., Dinkel, A., et al. (2025) · Healthcare · doi:10.3390/healthcare13172165 · Cited by 17
“Although the published version specified a 0–100 format, respondents were also permitted to use a 0–10 scale if preferred—a detail clarified through personal communication with the lead author of the FORT randomized controlled trial [56], which provided the validation data.”
InfluentialSelf-citationTutelman, P. R., Moran, C., Beattie, S., Khu, M., Howlett, M., Scheidl, J., Boychuk, A., Silveira, K., Henning, J., & Schulte, F. (2024) · Psycho-Oncology · doi:10.1002/pon.6335 · Cited by 12
“First, potential session topics were identified based on existing protocols, 14,17 review of AYA psychosocial needs and clinical practice guidelines, 18–20 and clinical experience.”
BackgroundMethodAguiar‐Ibáñez, R., Mbous, Y. P. V., Sharma, S., Chawla, E., & Pawar, D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1575813 · Cited by 12
Lyu, M., Siah, C. J. R., Zhao, J., & Cheng, K. K. F. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102360 · Cited by 7
Tock, W. L., Maheu, C., Blondin, S., Lee, V., Neuman, S., & Meterissian, S. H. (2025) · Psycho-Oncology · doi:10.1002/pon.70295 · Cited by 7
“Adjusting to life after treat-ment often brings new uncertainties, such as fear of cancer recurrence (FCR) [3] and declines in quality of life (QoL) [4].”
Self-citationLamarche, J., Ajmera, F., Avery, J., Sehabi, G., Lebel, S., & Nissim, R. S. (2025) · Current Oncology · doi:10.3390/curroncol32040209 · Cited by 6
“Importantly, there is evidence from two meta-analyses [9,10] that group and individual interventions, such as Fear Of Recurrence Therapy (FORT) [11], can successfully reduce clinical FCR among survivors.”
Self-citationLebel, S., Chu, A. K., Gourgues, F., Kearns, E., Prudent, A., Sehabi, G., Sehabi, W. Y., Beattie, S., Garland, S. N., Harris, C. A., et al. (2025) · Psycho-Oncology · doi:10.1002/pon.70293 · Cited by 5
Self-citationUrquhart, R., Kendell, C., & Lethbridge, L. N. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09242-x · Cited by 6
Fear of Cancer Recurrence in Women with Gynecological Cancer: A Systematic Review
Büyükokudan, Ş., & Körükcü, Ö. (2024) · Psycho-Oncologie · doi:10.32604/po.2024.046627 · Cited by 5
Lamarche, J., Nissim, R., Avery, J., Wong, J., Maheu, C., Lambert, S. D., Laizner, A. M., Jones, J., Esplen, M. J., & Lebel, S. (2024) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01567-4 · Cited by 4
“Cancer survivors in the experimental arm experienced FCR reductions five times greater than those in the control group (moderate effect size; d = − 0.53) [44].”
InfluentialSelf-citationLamarche, J., Nissim, R. S., Avery, J., Wong, J., Maheu, C., Lambert, S., Laizner, A. M., Jones, J. M., Esplen, M. J., & Lebel, S. (2025) · Psycho-Oncology · doi:10.1002/pon.70084 · Cited by 5
Self-citationEcosystem Barriers and Facilitators Linked to the Fear of Cancer Recurrence: An Umbrella Review
Caumeil, B., Bazine, N., Maugendre, A., & Calvin, S. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21081041 · Cited by 4
“Despite the fact that certain interventions appear to reduce FCR more directly than others, some interventions act as mediators and/or moderators of the relationship by promoting coping strategies focused on the problem and thus indirectly reducing FCR in a second instance [57].”
BackgroundNg, D. W. L., Ng, R., Guo, C., Chan, J., Fielding, R., Tang, J. W. C., Li, W. W. Y., Foo, C. C., Kwong, A., Ng, S. S. M., et al. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000547888 · Cited by 3
“%) coupled with the use of intention-to-treat approach [39], which likely diluted the intervention effect.”
Scruton, S., Hovey, C., Kendell, C., & Urquhart, R. (2025) · Current Oncology · doi:10.3390/curroncol32100570 · Cited by 3
“For example, common interventions include physical exercise programs [35–37], typically offered short term (i.e., a number of weeks or months), survivorship care plans and guidelines to assist in transitions after treatment completion [38–40], and fear of recurrence interventions [41,42].”
Interventions to Reduce Fear of Cancer Recurrence Among People With Cancer: Scoping Review
Li, N., Wensley, C. J., Reynolds, L., Baraza, W., Leyton, T. O., & Jull, A. (2026) · JMIR Cancer · doi:10.2196/81579 · Cited by 2
“%) studies evaluated the effect of blended interventions [31,32,34,35,37,40,42-44,46-50,53,61-63,67,72,89-91, 93,94,107,111,112,114,115,123,132,133,136,137,139-141].”
InfluentialSweeney, L., Schapira, L., Webster, S. N., Norton, S., Simons, L. E., Moss-Morris, R. E., & Heathcote, L. C. (2026) · Pain · doi:10.1097/j.pain.0000000000003951 · Cited by 2
Harris, C. A., Giguère, L., Chu, A. K., Lamarche, J., Langmuir, T., Menelas, K., Rutkowski, N. A., Sehabi, G., & Lebel, S. (2025) · Psycho-Oncology · doi:10.1002/pon.70140 · Cited by 1
“The Fear Of Recurrence Therapy (FORT) [18–20], that was developed to address fear of cancer recurrence (FCR) in cancer survivors (stages I‐III) may be particularly suited to adaptation in the AMI population.”
Self-citationSpiritual coping experience among young adults with advanced cancer in China: a qualitative study
Zhou, J., Zeng, C., Hu, Y. J., Zou, L., Li, Z., Xie, L., Zheng, X., & Huang, W. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09817-8 · Cited by 1
“This anxiety may stem from the limited efficacy of comprehensive cancer treatments, combined with prolonged physical discomfort, which further heightens the uncertainty surrounding treat-ment outcomes [36].”
Christie, A. J., Bolden, C., Park, E. R., Yeh, G. Y., O’Cleirigh, C. M., Lee, H., Peppercorn, J. M., Wagner, L. I., Henley, E., Traeger, L. N., et al. (2025) · Global Advances in Integrative Medicine and Health · doi:10.1177/27536130251407685 · Cited by 1
“29 The intervention showed medium effects for increasing acceptance, with signi fi cant between group differences 3 months post-treatment.”
Lamarche, J., Sehabi, G., Chu, A. K., Boudjatat, W. A., Giguère, L., Langmuir, T., Maheu, C., & Lebel, S. (2023) · Psycho-Oncology · doi:10.1002/pon.6127 · Cited by 1
Self-citationLyhne, J. D., Smith, A. B., Carstensen, T. B. W., Beatty, L., Bamgboje‐Ayodele, A., Klein, B., Jensen, L. H., & Frostholm, L. (2025) · JMIR Cancer · doi:10.2196/63486 · Cited by 1
“Several psycho-oncological interventions have undergone successful adaptations, for example FindingMyWay [20] from Australia and Fear Of Recurrence Therapy [21] from Canada.”
Smith, B., Wu, V. S., Pearce, A. M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8889572/v1 · Cited by 1
Chow, K. M., Luo, G., Chan, C. W. H., Choi, K. C., Chair, S. Y., Shi, Z., & Leung, A. W. Y. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09460-3 · Cited by 1
Managing, not lessening, uncertainty: a novel mind–body intervention for fear of cancer recurrence
Christie, A. J., Bolden, C., Park, E. R., Yeh, G. Y., O’Cleirigh, C. M., Peppercorn, J. M., Denninger, J. W., Hirschberg, A., Lee, H., Markwart, M., et al. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01886-2 · Cited by 2
The experience of fear of recurrence in Mexican breast cancer survivors: a qualitative study
Bazan-Muñoz, J., Lebel, S., Monroy-López, A., Riveros-Rosas, A., Caballero-Suárez, N. P., Bermúdez-Pavón, M., & Gálvez‐Hernández, C. L. (2025) · Journal of Psychosocial Oncology Research and Practice · doi:10.1097/or9.0000000000000182 · Cited by 1
Self-citationAddressing Fear of Cancer Recurrence Through Remotely‐Delivered Exercise
Bergerot, C. D., Schmitz, K. H., Philip, E. J., Silva, J. R. G., Smith, A. B., & Bergerot, P. G. (2026) · Psycho-Oncology · doi:10.1002/pon.70383 · Cited by 1
Smith, B., Wu, V. S., Pearce, A., Liu, J., Shepherd, H. L., Shaw, J., Girgis, A., Garvey, G., Kirsten, L. T., Zakhary, I., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11275-9 · Cited by 1
Eficacia de los tratamientos psicológicos para el miedo a la recurrencia del cáncer de mama
Reyes, A. V., & Cruzado, J. A. (2023) · Psicooncología · doi:10.5209/psic.91524
Group-based psychological interventions for fear of cancer recurrence: A scoping review protocol
O'Brien, C., Lowery, M. A., Mockler, D., Guinan, E. M., Darley, A., Guérin, S., Collier, S., O'Riordan, B., & Pertl, M. (2025) · HRB Open Research · doi:10.12688/hrbopenres.14013.1
Park, S., & Park, S. (2025) · Asian Social Work and Policy Review · doi:10.1111/aswp.70018
Eyrenci, A., Ertuna, L., & Bahçivan, O. (2025) · Psycho-Oncology · doi:10.1002/pon.70345
“Randomized controlled trials conducted in Canada have demonstrated its efficacy in reducing FCR, anxiety, and depression, as well as improving quality of life, with recent online formats showing promising feasibility and accessibility for underserved survivors [5, 7, 8, 46].”
InfluentialSapone, C., Scuotto, C., Ciarmoli, D., Carruba, M. C., Savioni, L., & Triberti, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-08980-9_26
Fang, C., Li, Y., Cheng, Y., Liu, Q., Hu, L., & Zhang, C. (2026) · Psycho-Oncology · doi:10.1002/pon.70423
“Rather than merely forecasting risk, our aim is to provide psycho‐oncologists and clinicians with reliable tools for early identification of individuals prone to elevated FCR [16], thereby enabling timely, targeted, and patient‐centered interventions [17].”
Qian, J., Wang, R., Jevitt, C., Sun, S., Wang, M., Sun, Y., Sun, X., & Yu, X. (2026) · Cancer Nursing · doi:10.1097/ncc.0000000000001565 · Cited by 1
Pamuk, K., & Karaca, A. (2026) · Journal of Rational-Emotive & Cognitive-Behavior Therapy · doi:10.1007/s10942-026-00652-2
“…quality of life, depression and anxiety lev - els, sexual problems, fear of recurrence, and hope levels (Bell et al., 2022; Brotto et al., 2012; León-Pizarro et al., 2007; Maheu et al., 2023; Manne et al., 2017; Padron et al., 2022; Rieger et al., 2023; Vianna et al., 2013; Wiswell et al., 2019).”
Neves, M. C., Custers, J. A. E., Prins, J. B., Nunes, F., Monteiro, S. O. M., & Sales, C. (2026) · Journal of Adolescent and Young Adult Oncology · doi:10.1177/21565333261451809
Gelashvil, A., Владиславович, Б. Д., & Солопова, А. Г. (2026) · Vrach · doi:10.29296/25877305-2026-01-02
Eyrenci, A., Ertuna, L., & Bahçivan, O. (2026) · BMC Psychology · doi:10.1186/s40359-026-04915-6
“In addition to its therapeutic components, the group-based delivery format provides opportunities for peer support and shared experiences, which may further contribute to improved coping and emotional adjustment among survivors [13–15].”
Holy, C., Brinson, J., Gibson-Haerle, J., Russell, K. B., Abbott, L. S., Giguère, L., Givogue, A., Guilcher, G. M. T., Heathcote, L. C., Johnson, E., et al. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1815418
“These findings are consistent with the broader adult literature, including evidence that a targeted FCR intervention was superior at reducing this concern compared to a structurally equivalent support group that discussed general survivorship topics (Maheu et al., 2023).”
InfluentialSelf-citationVanlaer, N., Testaferrata, C., Decabooter, L., Dirven, I., Bertels, C., Stas, L., Van Eycken, S., Hein, M., Neyns, B., & Rogiers, A. (2026) · Cancers · doi:10.3390/cancers18050785
Priyanto, P., & Sutrisni, S. T. (2026) · Proceeding International Collaborative Conference on Multidisciplinary Science · doi:10.70062/iccms.v3i1.247
Ji, P., Xiao, Y., & Kong, J. (2026) · Cancer Plus · doi:10.36922/cp026160026
Metadata
- Authors
- Maheu, C., Lebel, S., Bernstein, L. J., Courbasson, C., Singh, M., Ferguson, S. E., Harris, C., Jolicoeur, L., Baku, L., Muraca, L., Ramanakumar, A. V., Lamonde, F., Lefebvre, M., Tomei, C., Mutsaers, B., Secord, S., Power, J., Drummond, N., Hébert, M., & Wani, R. J.
- Affiliations
- McGill University (CA)
- University of Ottawa (CA)
- University Health Network (CA)
- York University (CA)
- Ottawa Hospital (CA)
- University of Waterloo (CA)
- Mount Sinai Hospital (CA)
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- Université du Québec à Trois-Rivières (CA)
- ORCID
- Venue
- Health Psychology
- Published
- 2023-03
- Volume
- 42
- Issue
- 3
- Pages
- 182-194
- ISSN
- 0278-6133 (ISSN-L)
- 1930-7810
- OpenAlex
- W4322757424
- Cited by
- 43
- References
- 0
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 5 · 2023: 4
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-07-13)
- Open access
- hybrid
- doi.org
- Locations
- Health Psychology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- Réseau de recherche en interventions en sciences infirmières du Québec/Quebec Network on Nursing Interventions Research
- McGill University
- Canadian Cancer Society Research Institute (702589)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of cancer recurrence, breast cancer survivors, gynecologic cancer survivors, cancer-related distress, coping, cognitive avoidance, reassurance seeking, quality of life, booster sessions, psycho-oncology
- MeSH terms
- Cancer Survivors, Adaptation, Psychological, Fear, Female, Humans, Neoplasms, Phobic Disorders, Recurrence, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.